Domů › Squamózní buněčný karcinom hlavy a krku › Missouri › St. Louis
Klinické studie Squamózní buněčný karcinom hlavy a krku v St. Louis, MO
28 studií pro Squamózní buněčný karcinom hlavy a krku hledá účastníky v lokalitách v St. Louis a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Probíhá náborFáze 3
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · Vzdálenost 16 mi
- a dalších 1
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Probíhá náborFáze 1
- Washington University School of Medicine in St. Louis, St Louis
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Probíhá náborFáze 2/3
- Site #0114, St Louis
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Probíhá náborFáze 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- a dalších 4
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Probíhá náborFáze 3
- Washington University School Of Medicine, St Louis
- Cancer Care Specialists of Central Illinois, O'Fallon · Vzdálenost 16 mi
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Probíhá náborFáze 1/2
- Washington University School Of Medicine, St Louis
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- a dalších 4
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Probíhá náborFáze 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- HSHS Saint Elizabeth's Hospital, O'Fallon · Vzdálenost 16 mi
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Probíhá náborFáze 1/2
- Washington University, St Louis
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Probíhá náborFáze 1/2
- Washington Univ. School of Medicine, St Louis
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Probíhá náborFáze 2
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- a dalších 4
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Washington University, St Louis
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Probíhá náborFáze 1
- Washington University, St Louis
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Probíhá náborObservační studie
- Washington University in St. Louis, St Louis
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Research Site, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Probíhá náborFáze 1
- Normunity Investigational Site, St Louis
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Probíhá náborFáze 2/3
- SSM Health Saint Louis University Hospital, St Louis
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Probíhá náborFáze 3
- Cancer Care Center of O'Fallon, O'Fallon · Vzdálenost 16 mi
- HSHS Saint Elizabeth's Hospital, O'Fallon · Vzdálenost 16 mi
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Washington University School of Medicine at St Louis, St Louis
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Washington University, St Louis
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Probíhá náborFáze 3
- GSK Investigational Site, St Louis
5-Fluorouracil Response and Optimization STudy (The FROST Trial)
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Probíhá náborFáze 3
- Siteman Cancer Center - Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Washington University, St Louis
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Probíhá nábor
- Washington University in St. Louis, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Probíhá náborFáze 1/2
- Washington University, St Louis
Validity of Viome's Oral/throat Cancer Test
Probíhá náborObservační studie
- Missouri School of Dentistry & Oral Health, St Louis
Studie Squamózní buněčný karcinom hlavy a krku v jiných městech
- Houston, TX47 studií
- Los Angeles, CA42 studií
- Boston, MA40 studií
- New York City, NY39 studií
- Nashville, TN39 studií
- Arlington, VA26 studií
- Chicago, IL26 studií
- Philadelphia, PA26 studií
- Atlanta, GA24 studií
- San Antonio, TX22 studií
- New Haven, CT22 studií
- Pittsburgh, PA22 studií
Další studie v St. Louis
- Nemalobuněčný plicní karcinom73 studií
- Rakovina prsu64 studií
- Metastatický karcinom54 studií
- Kolorektální karcinom50 studií
- Rakovina (všechny typy)46 studií
- Rakovina prostaty46 studií
- Rakovina plic39 studií
- Rakovina vaječníků38 studií
- Rakovina slinivky břišní33 studií
- Rakovina endometria29 studií
- Srdeční selhání26 studií
- Obesity25 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.